H.R. 2319

Summary

H.R. 2319, the Women and Lung Cancer Research and Preventive Services Act of 2025, was introduced in the House on Mar 25, 2025 by Rep. Brendan Boyle (D) with 2 co-sponsors. It last saw action on Apr 22, 2026: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

Record

Text

H.R. 2319 has 2 co-sponsors.

119 HR 2319 EH: Women and Lung Cancer Research and Preventive Services Act of 2025
 U.S. House of Representatives
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 IB
 119th CONGRESS  2d Session
 H. R. 2319
 IN THE HOUSE OF REPRESENTATIVES
 AN ACT
To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.
1.
Short title
This Act may be cited as the   Women and Lung Cancer Research and Preventive Services Act of 2025  .
2.
Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns
(a)
In general
The Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to—
(1)
research on lung cancer in women;
(2)
research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;
(3)
access to lung cancer preventive services; and
(4)
strategic public awareness and education campaigns on lung cancer.
(b)
Content
The review and recommendations under subsection (a) shall include—
(1)
a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;
(2)
opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—
(A)
encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;
(B)
evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and
(C)
foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;
(3)
opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and
(4)
opportunities regarding the development of a national public education and awareness campaign on—
(A)
lung cancer in women and underserved populations; and
(B)
the importance of early detection of lung cancer.
(c)
Report
Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).
     Passed the House of Representatives April 21, 2026.  Kevin F. McCumber,  Clerk.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Rep. Brendan Boyle (D) sponsors H.R. 2319, and 2 members have co-sponsored it.

Brendan Boyle

Rep. · D–PA-2 · Sponsor

Introduced Mar 25, 2025

Brian Fitzpatrick

Rep. · R–PA-1 · Co-sponsor

Joined Mar 31, 2025

Juan Ciscomani

Rep. · R–AZ-6 · Co-sponsor

Joined Sep 15, 2025

Show 3 of 3 rows

PreviousNext

Committees

H.R. 2319 went before 1 committee: Energy and Commerce.

Energy and Commerce

Energy and Commerce

Reported By · Nov 18, 2025 · 1,636 Bills

Reports

1 committee report has been filed on H.R. 2319, the latest H. Rept. 119-382.

• H. Rept. 119-382 — WOMEN AND LUNG CANCER RESEARCH AND PREVENTIVE SERVICES ACT OF 2025

Actions

H.R. 2319 has taken 13 actions since Mar 25, 2025, the latest on Apr 22, 2026.

Votes

H.R. 2319 has not gone to a roll call.

Related bills

1 bill is related to H.R. 2319, as Identical bill.

S 1157Women and Lung Cancer Research and Preventive Services Act of 2025Jun 9, 2026 · Held at the desk. · Identical bill

Show 1 of 1 row

PreviousNext

Titles

H.R. 2319 goes by 7 titles, 4 of them short titles.

• Women and Lung Cancer Research and Preventive Services Act of 2025 — Display Title
• Women and Lung Cancer Research and Preventive Services Act of 2025 — Short Title(s) from PCS (Placed on Senate Calendar) bill text
• Women and Lung Cancer Research and Preventive Services Act of 2025 — Short Title(s) as Passed House
• To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes. — Official Titles from EH (Engrossed in House) bill text
• Women and Lung Cancer Research and Preventive Services Act of 2025 — Short Title(s) as Reported to House
• Women and Lung Cancer Research and Preventive Services Act of 2025 — Short Title(s) as Introduced
• To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes. — Official Title as Introduced

Cost estimate

The Congressional Budget Office has filed 1 estimate for H.R. 2319, the latest on Aug 14, 2025.

• H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 — 2025-08-14As ordered reported by the House Committee on Energy and Commerce on April 29, 2025

Lobbying

7 clients hired 7 firms and 33 registered lobbyists who named H.R. 2319 in 34 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Medicare/Medicaid, Budget/Appropriations, Taxation/Internal Revenue Code, Education, Medical/Disease Research/Clinical Labs, Defense, Labor Issues/Antitrust/Workplace.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 33.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 2319 under Health, one of its 31 policy areas, and gives it 8 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 2319’s is Health.

Legislative Subjects

H.R. 2319 carries 8 of CRS’s legislative subjects, from Cancer to Women's health.

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 2319, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 54 (Tuesday, March 25, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. BOYLE of Pennsylvania:H.R. 2319.Congress has the power to enact this legislation pursuantto the following:Spending Clause, Article 1, Section 8, Cl. 1 and theNecessary and Proper Clause, Article I, Section 8, Cl. 18.[Page H1274]

Source: congress.gov · legiscan.com